Abstract

IntroductionThe complexity of immunity to malaria is well known, and clear correlates of protection against malaria have not been established. A better understanding of immune markers induced by candidate malaria vaccines would greatly enhance vaccine development, immunogenicity monitoring and estimation of vaccine efficacy in the field. We have previously reported complete or partial efficacy against experimental sporozoite challenge by several vaccine regimens in healthy malaria-naïve subjects in Oxford. These include a prime-boost regimen with RTS,S/AS02A and modified vaccinia virus Ankara (MVA) expressing the CSP antigen, and a DNA-prime, MVA-boost regimen expressing the ME TRAP antigens. Using samples from these trials we performed transcriptional profiling, allowing a global assessment of responses to vaccination. MethodsWe used Human RefSeq8 Bead Chips from Illumina to examine gene expression using PBMC (peripheral blood mononuclear cells) from 16 human volunteers. To focus on antigen-specific changes, comparisons were made between PBMC stimulated with CSP or TRAP peptide pools and unstimulated PBMC post vaccination. We then correlated gene expression with protection against malaria in a human Plasmodium falciparum malaria challenge model. ResultsDifferentially expressed genes induced by both vaccine regimens were predominantly in the IFN-γ pathway. Gene set enrichment analysis revealed antigen-specific effects on genes associated with IFN induction and proteasome modules after vaccination. Genes associated with IFN induction and antigen presentation modules were positively enriched in subjects with complete protection from malaria challenge, while genes associated with haemopoietic stem cells, regulatory monocytes and the myeloid lineage modules were negatively enriched in protected subjects. ConclusionsThese results represent novel insights into the immune repertoires involved in malaria vaccination.

Highlights

  • The complexity of immunity to malaria is well known, and clear correlates of protection against malaria have not been established

  • Antigen-specific changes in expression of genes from donors vaccinated with RTS,S/AS02A and modified vaccinia virus Ankara (MVA)-CS (CSP study)

  • Transcriptional profiles were compared in Peripheral blood mononuclear cells (PBMC) stimulated with circumsporozoite protein (CSP) and paired unstimulated PBMC in samples from eight volunteers 28 days post-vaccination with RTS,S/AS02A and MVA-CS. 128 genes were differentially expressed with the significance level at P < 0.01 and 744 genes were differentially expressed with the significance level at P < 0.05

Read more

Summary

Introduction

The complexity of immunity to malaria is well known, and clear correlates of protection against malaria have not been established. We have previously reported complete or partial efficacy against experimental sporozoite challenge by several vaccine regimens in healthy malaria-naïve subjects in Oxford. These include a prime-boost regimen with RTS,S/AS02A and modified vaccinia virus Ankara (MVA) expressing the CSP antigen, and a DNA-prime, MVA-boost regimen expressing the ME TRAP antigens. Using samples from these trials we performed transcriptional profiling, allowing a global assessment of responses to vaccination. Results: Differentially expressed genes induced by both vaccine regimens were predominantly in the IFN-␥ pathway. Dunachie et al / Vaccine 33 (2015) 5321–5331 antibodies [7,8] but vaccination mediated CD4+ T-cell responses occur [9,10,11]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call